Similarly, TP53 codon 72 polymorphism is susceptible to cause lung cancer, according to many previous studies (Hossain et al., 2017; Pierce et al., 2000; Hiraki et al., 2003; Sakiyama et al., 2005; Zhang et al., 2006; Jung et al., 2008; Piao et al., 2011). Here, TP53 is linked to lung cancer.